Multisystem Inflammatory Syndrome in a 12-Year-old Boy After mRNA-SARS-CoV-2 Vaccination
Open Access
- 21 December 2021
- journal article
- research article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 41 (3) , e93-e94
Abstract
Multisystem inflammatory syndrome in children (MIS-C) following SARS-CoV-2 infection is well known. We describe a 12-year-old child developing MIS-C after receiving 2 doses of mRNA COVID-19 vaccines without clinical evidence of COVID-19 infection. A possible association between the SARS-CoV-2 vaccine and MIS-C cannot be excluded.Keywords
This publication has 5 references indexed in Scilit:
- Fatal Multisystem Inflammatory Syndrome in Adult after SARS-CoV-2 Natural Infection and COVID-19 VaccinationEmerging Infectious Diseases, 2021
- Multisystem inflammatory syndrome in a male adolescent after his second Pfizer‐BioNTech COVID‐19 vaccineActa Paediatrica, 2021
- Multisystem inflammatory syndrome in an adult following the SARS-CoV-2 vaccine (MIS-V)BMJ Case Reports, 2021
- Multisystem Inflammatory Syndrome after SARS-CoV-2 Infection and COVID-19 VaccinationEmerging Infectious Diseases, 2021
- Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety dataVaccine, 2021